Acadia Healthcare Company, Inc. $ACHC Shares Sold by Counterpoint Mutual Funds LLC

Counterpoint Mutual Funds LLC reduced its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 57.7% during the 1st quarter, HoldingsChannel reports. The firm owned 23,483 shares of the company’s stock after selling 32,038 shares during the period. Counterpoint Mutual Funds LLC’s holdings in Acadia Healthcare were worth $549,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Acadia Healthcare in the 1st quarter valued at $1,600,000. Goldman Sachs Group Inc. raised its position in Acadia Healthcare by 21.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after buying an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after buying an additional 27,207 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Acadia Healthcare by 531.5% in the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after acquiring an additional 88,995 shares during the period. Finally, Prudential Financial Inc. boosted its holdings in shares of Acadia Healthcare by 21.9% in the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after acquiring an additional 1,780 shares in the last quarter.

Analyst Ratings Changes

ACHC has been the topic of a number of recent analyst reports. Barclays boosted their price target on shares of Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 30th. UBS Group lifted their price objective on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price on the stock in a research report on Monday, May 4th. Jefferies Financial Group raised Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Finally, KeyCorp reissued an “overweight” rating and issued a $30.00 price target on shares of Acadia Healthcare in a report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and an average target price of $26.85.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $31.91 on Friday. The company has a 50-day simple moving average of $25.70 and a 200-day simple moving average of $21.24. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The company has a market capitalization of $2.93 billion, a PE ratio of -2.61, a P/E/G ratio of 10.64 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $32.82.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. During the same quarter in the previous year, the firm earned $0.40 earnings per share. The firm’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities research analysts predict that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.